[Pimafucin in the therapy of vaginal infections caused by blastomyces and trichomonas].
D000935:Antifungal Agents / Q000008:administration & dosage*; D001758:Blastomyces / Q000302:isolation & purification; D001759:Blastomycosis / Q000188:drug therapy; D003470:Culture Media; D046508:Culture Techniques; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D010866:Natamycin / Q000008:administration & dosage; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious; D014244:Trichomonas / Q000302:isolation & purification; D014247:Trichomonas Vaginitis / Q000188:drug therapy; D014627:Vaginitis / Q000188:drug therapy*
D000935:Antifungal Agents; D003470:Culture Media; D010866:Natamycin
Pimafucin bei der Behandlung von Infektionen der Vagina durch Sprosspilze und Trichomonaden.